Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis

BACKGROUND: Mortality from cryptococcal meningitis remains very high in Africa. In the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) trial, 2 weeks of fluconazole (FLU) plus flucytosine (5FC) was as effective and less costly than 2 weeks of amphotericin-based regimens. However, many...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Clin Infect Dis
Main Authors: Shiri, Tinevimbo, Loyse, Angela, Mwenge, Lawrence, Chen, Tao, Lakhi, Shabir, Chanda, Duncan, Mwaba, Peter, Molloy, Síle F, Heyderman, Robert S, Kanyama, Cecilia, Hosseinipour, Mina C, Kouanfack, Charles, Temfack, Elvis, Mfinanga, Sayoki, Kivuyo, Sokoine, Chan, Adrienne K, Jarvis, Joseph N, Lortholary, Olivier, Jaffar, Shabbar, Niessen, Louis W, Harrison, Thomas S
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2020
נושאים:
Articles and Commentaries
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6912152/
https://ncbi.nlm.nih.gov/pubmed/30816418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz163
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים